Teriparatide
تریپاراتاید
🧬 Systemic Hormonal Preparations, Excl. Sex Hormones And InsulinsParathyroid hormone analogue (bone anabolic)
Market / country: 🇺🇸 USA
Forteo (US)
🧮 Dose calculator
Osteoporosis / calcium and vitamin D deficiency · Regimen source: FDA Forteo · 2.1
- • Into the thigh or abdomen. Give the first doses sitting or lying down (orthostatic hypotension). FDA Forteo · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to teriparatide or its excipients. FDA Forteo · 4
Formulations
- Pen 250 mcg/mL (20 mcg per dose) — injection 🇺🇸 USA FDA Forteo · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Forteo · 8.1
“Risk Summary There are no available data on FORTEO use in pregnant women to evaluate for drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Forteo · 8.2
“Avoid FORTEO use in women who are breastfeeding.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Forteo · 8.4
“The safety and effectiveness of FORTEO have not been established in pediatric patients.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Forteo · 8.5
“No overall differences in safety or effectiveness of FORTEO have been observed between patients 65 years of age and older and younger adult patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA021318
- DailyMed (FDA label)FDA Forteo
- MedlinePlus (NIH)Palopegteriparatide InjectionTeriparatide Injection
- WHO ATC/DDDH05AA02
- Darooyab (Iran)Teriparatide
🇮🇷 Registered in Iran Darooyab · G-1446/Teriparatide
Dosage forms with Iranian generic codes, per Darooyab.
- 11464 · TERIPARATIDE 250MCG/ML 2.4ML INJ · فرآورده تزریقی تریپاراتاید ۲۵۰ میکروگرم / میلیلیتر ۲٫۴ میلیلیتر
- 06027 · TERIPARATIDE 750MCG/3ML VIAL · ویال تریپاراتاید ۷۵۰ میکروگرم / ۳ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Forteo · 3FDA Forteo · 2.1FDA Forteo · 2.2FDA Forteo · 4FDA Forteo · 8.1FDA Forteo · 8.2FDA Forteo · 8.4FDA Forteo · 8.5FDA Forteo · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1446/Teriparatide
- Clinical review⚠ Unverified